Franziska Olm
Overview
Explore the profile of Franziska Olm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hirdman G, Stenlo M, Bechet N, Niroomand A, Mittendorfer M, Wang Q, et al.
Transplantation
. 2025 Feb;
PMID: 39969856
Background: Lung transplantation remains hampered by a scarcity of viable donor lungs, partially attributed to donor lung injuries. Methods: Three porcine lung injury models were studied: infection-induced using lipopolysaccharide (n ...
2.
Svobodova B, Lofdahl A, Nybom A, Wigen J, Hirdman G, Olm F, et al.
Biomedicines
. 2025 Jan;
12(12.
PMID: 39767799
A novel patient group with chronic pulmonary fibrosis is emerging post COVID-19. To identify patients at risk of developing post-COVID-19 lung fibrosis, we here aimed to identify systemic proteins that...
3.
Bechet N, Celik A, Mittendorfer M, Wang Q, Huzevka T, Kjellberg G, et al.
J Heart Lung Transplant
. 2024 Nov;
44(3):448-459.
PMID: 39536924
Background: Ischemia-reperfusion injury (IRI) plays a crucial role in the development of primary graft dysfunction (PGD) following lung transplantation. A promising novel approach to optimize donor organs before transplantation and...
4.
Edstrom D, Niroomand A, Stenlo M, Broberg E, Hirdman G, Ghaidan H, et al.
J Heart Lung Transplant
. 2024 Aug;
43(12):2018-2030.
PMID: 39182800
Background: Lung transplantation is hindered by low donor lung utilization rates. Infectious complications are reasons to decline donor grafts due to fear of post-transplant primary graft dysfunction. Mesenchymal stem cells...
5.
Mittendorfer M, Pierre L, Huzevka T, Schofield J, Abrams S, Wang G, et al.
J Heart Lung Transplant
. 2024 Jul;
43(12):1919-1929.
PMID: 39038563
Background: By causing inflammation and tissue damage, neutrophil extracellular traps (NETs) constitute an underlying mechanism of aspiration-induced lung injury, a major factor of the low utilization of donor lungs in...
6.
Niroomand A, Hirdman G, Bechet N, Ghaidan H, Stenlo M, Kjellstrom S, et al.
Transpl Int
. 2024 May;
37:12298.
PMID: 38741700
Primary graft dysfunction (PGD) remains a challenge for lung transplantation (LTx) recipients as a leading cause of poor early outcomes. New methods are needed for more detailed monitoring and understanding...
7.
Lindstedt S, Wang Q, Niroomand A, Stenlo M, Hyllen S, Pierre L, et al.
Sci Rep
. 2024 Mar;
14(1):6662.
PMID: 38509285
Acute lung injury (ALI) represents an aetiologically diverse form of pulmonary damage. Part of the assessment and diagnosis of ALI depends on skilled observer-based scoring of brightfield microscopy tissue sections....
8.
Bergwik J, Bhongir R, Padra M, Adler A, Olm F, Lang P, et al.
Immunology
. 2024 Jan;
171(4):583-594.
PMID: 38178705
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disorder involving scarring of pulmonary tissue and a subsequent decrease in respiratory capacity, ultimately resulting in death. Tartrate resistant acid phosphatase 5...
9.
Niroomand A, Hirdman G, Pierre L, Ghaidan H, Kjellstrom S, Stenlo M, et al.
Front Cardiovasc Med
. 2023 Oct;
10:1274444.
PMID: 37849943
Introduction: In recent years, the field of graft preservation has made considerable strides in improving outcomes related to solid organ restoration and regeneration. Ex vivo lung perfusion (EVLP) in line...
10.
Petruk G, Puthia M, Samsudin F, Petrlova J, Olm F, Mittendorfer M, et al.
Nat Commun
. 2023 Oct;
14(1):6436.
PMID: 37833291
No abstract available.